Stock PODD INSULET CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Insulet Corporation

Equities

PODD

US45784P1012

Delayed Nasdaq
Other stock markets
 03:52:25 2024-04-18 pm EDT 		5-day change 1st Jan Change
164 USD -1.36% Intraday chart for Insulet Corporation -8.54% -24.28%
Mar. 20 US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady MT
Mar. 20 Insulet Names Ana Maria Chadwick Finance Chief MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
BU
US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady
MT
Insulet Names Ana Maria Chadwick Finance Chief
MT
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
BU
Insulet Corporation Appoints Ana Maria Chadwick as Executive Vice President, and Treasurer, Effective April 22, 2024
CI
Insulet Corporation Announces Chief Financial Officer Changes
CI
3M Board Approves Healthcare Unit Spinoff -- Update
DJ
Transcript : Insulet Corporation - Special Call
Insulet Says Trial Shows Omnipod 5 Insulin Delivery System Superior to Pump Therapy
MT
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
BU
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)
CI
Insulet to Present Results from First Omnipod 5 Randomized Controlled Trial at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
AQ
Transcript : Insulet Corporation Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 11:35 AM
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
BU
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes
CI
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership
Our Logo
Barclays Trims Insulet Price Target to $213 From $214, Maintains Equal Weight Rating
MT
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
AQ
Insulet forecasts weak annual revenue growth; shares drop
RE
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PODD Stock
  4. News Insulet Corporation